Scarica l'app Stockscreener
4.30
1.42%
0.06
Hookipa Pharma Inc Borsa (HOOK) Ultime notizie
HOOKIPA Pharma's SWOT analysis: stock's potential in cancer immunotherapy - Investing.com
HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) 26% Dip In Price Shows Sentiment Is Matching Revenues - Simply Wall St
HOOKIPA presents KRAS cancer treatment data By Investing.com - Investing.com South Africa
HOOKIPA presents KRAS cancer treatment data - Investing.com India
HOOKIPA presents KRAS cancer treatment data - Investing.com
HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset - Marketscreener.com
HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset - StockTitan
Squamous Cell Carcinoma Clinical Trial Pipeline Insights: 75+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | DelveInsight - GlobeNewswire Inc.
Kaskela Law LLC Announces Shareholder Investigation of HOOKIPA Pharma Inc. (NASDAQ: HOOK) and Encourages Investors to Contact the Firm | FinancialContent Business Page - Financial Content
How To Trade (HOOK) - Stock Traders Daily
Wall Street Analysts Think HOOKIPA Pharma (HOOK) Could Surge 622.75%: Read This Before Placing a Bet - MSN
Wall Street Analysts Think HOOKIPA Pharma (HOOK) Could Surge 622.75%: Read This Before Placing a Bet - Yahoo Finance
HOOKIPA appoints new Non-Executive Chair as two members exit - Investing.com India
HOOKIPA appoints new Non-Executive Chair as two members exit By Investing.com - Investing.com South Africa
HOOKIPA Pharma Announces Board of Directors Changes - citybiz
HOOKIPA appoints new Non-Executive Chair as two members exit By Investing.com - Investing.com UK
Hookipa Pharma Announces Board Restructuring and Appointments - TipRanks
HOOKIPA Pharma Announces Board of Directors Changes - Quantisnow
HOOKIPA appoints new Non-Executive Chair as two members exit - Investing.com
HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Hookipa Pharma Inc (NASDAQ:HOOK) Short Interest Update - MarketBeat
Will HOOKIPA Pharma Inc. (HOOK) Report Negative Q2 Earnings? What You Should Know - MSN
HOOK (HOOKIPA Pharma) 3-Year FCF Growth Rate : 25.90% (As of Jun. 2024) - GuruFocus.com
HOOK (HOOKIPA Pharma) 3-Year Revenue Growth Rate : -34.30% (As of Jun. 2024) - GuruFocus.com
The Market Doesn't Like What It Sees From HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) Revenues Yet As Shares Tumble 29% - Simply Wall St
HOOKIPA Pharma Second Quarter 2024 Earnings: Revenues Miss Expectations - Yahoo Finance
HOOK Stock Earnings: HOOKIPA Pharma Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace
The Globe and Mail - The Globe and Mail
HOOKHOOKIPA Pharma Inc. Latest Stock News & Market Updates - StockTitan
SEC Form 10-Q filed by HOOKIPA Pharma Inc. - Quantisnow
HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights - ForexTV.com
HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
HOOKIPA Pharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits - Quantisnow
HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights - Yahoo Finance
Wall Street Analysts Believe HOOKIPA Pharma (HOOK) Could Rally 634.38%: Here's is How to Trade - Yahoo Canada Finance
Wall Street Analysts Believe HOOKIPA Pharma (HOOK) Could Rally 634.38%: Here's is How to Trade - Yahoo Finance
HOOK (HOOKIPA Pharma) Market Cap : $51.06 Mil (As of Aug. 02, 2024) - GuruFocus.com
Will HOOKIPA Pharma Inc. (HOOK) Report Negative Q2 Earnings? What You Should Know - Yahoo Finance
Hookipa Pharma Inc (NASDAQ:HOOK) Short Interest Up 47.1% in July - MarketBeat
Hookipa Pharma (NASDAQ:HOOK) versus AC Immune (NASDAQ:ACIU) Critical Comparison - Defense World
Hookipa Pharma (NASDAQ:HOOK) PT Lowered to $23.00 - Defense World
Hookipa Pharma (NASDAQ:HOOK) PT Lowered to $23.00 at JMP Securities - MarketBeat
Q2 2024 EPS Estimates for Hookipa Pharma Inc (NASDAQ:HOOK) Lifted by Analyst - MarketBeat
Hookipa Pharma Announces Executive Reshuffle and Board Enhancements - TipRanks
Hookipa Pharma Inc (NASDAQ:HOOK) Forecasted to Earn Q2 2024 Earnings of ($1.48) Per Share - Defense World
HOOKIPA Pharma appoints new CEO and CFO, reviews strategy - Investing.com India
HOOKIPA Pharma appoints new CEO and CFO, reviews strategy - Investing.com
HOOKIPA Pharma Appoints Dr. Malte Peters as CEO - citybiz
HOOKIPA Pharma Announces Director Dr. Malte Peters Named CEO And Director Terry Coelho Named Executive Vice President And CFO - Quantisnow
HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200 - GlobeNewswire
HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200 - Yahoo Finance
HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200 - WDRB
Nima Farzan named CEO of Latigo - BioCentury
Hookipa Pharma (NASDAQ:HOOK) Sees Unusually-High Trading Volume - Defense World
Hookipa Pharma (NASDAQ:HOOK) Sees Strong Trading Volume - American Banking and Market News
Hookipa Pharma (NASDAQ:HOOK) Shares Gap Down to $5.09 - Defense World
Hookipa Pharma (NASDAQ:HOOK) Shares Gap Down to $5.09 - American Banking and Market News
Short Interest in Hookipa Pharma Inc (NASDAQ:HOOK) Decreases By 85.7% - MarketBeat
Hookipa Pharma (NASDAQ:HOOK) Sees Strong Trading Volume - MarketBeat
Hookipa Pharma (NASDAQ:HOOK) Shares Gap Down to $5.09 - MarketBeat
Why HOOKIPA Pharma (HOOK) Stock Is Volatile Today - MSN
HOOKIPA Pharma enacts 1-for-10 reverse stock split By Investing.com - Investing.com Nigeria
HOOKIPA Pharma enacts 1-for-10 reverse stock split - Investing.com
It makes sense and dollars to buy Hookipa Pharma Inc (HOOK) stock - SETE News
HOOKIPA Pharma enacts 1-for-10 reverse stock split By Investing.com - Investing.com UK
Hookipa Pharma Inc (HOOK) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle
Market Highlights: Hookipa Pharma Inc (HOOK) Ends on a Low Note at 0.51 - The Dwinnex
0.05%
4.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):